Charles River Laboratories International Inc. Stock Rises 7.2%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. rose 7.2% to $240.43 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,428.78 and the Dow Jones Industrial Average rising 1.0% to 52,747.32.

The stock's rise snapped a two-day losing streak.

Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $238.85, which the company achieved on July 23rd.

The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 4.3% to $314.23, Alnylam Pharmaceuticals Inc. rose 3.6% to $288.41, and Bio-Techne Corp. rose 0.63% to $72.07.

Trading volume totaled 1.3 million, compared to the 50-day average of 889,214.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 28, 2026 16:34 ET (20:34 GMT)